Efficacy and Safety of Initial Low-Dose Triple CombinationTherapy for Hypertension: A Systematic Review and Meta-Analysis
by Prateek Chopra | June 10, 2026 | Cardiology Conferences | ESH 2026 Context and Rationale: Single-pill triple low-dose combination (triple-LDC) antihypertensive therapies have emerged as an alternative initial treatment strategy, expanding options beyond conventional monotherapy. The therapy aims to improve BP control while minimizing adverse effects by using ≤50% of standard doses for each component. Study Design: Trial Population and […]